This week I am completing the fifth twenty-eight day cycle on pomalidomide and dexamethasone. In the middle of the month I had my regular blood work which showed that the free light chains had dropped for the first time in a few cycles. They are now at 214. While this is good news the number is still higher than my hematologist would like in order to lower the risk of organ damage due to amyloidosis. He advises that we add cyclophosphamide to the treatment. This is in pill form, taken once weekly. I will receive a low dose and should not experience any additional side effects. I received cyclophosphamide for six months while being treated with bortezomib (Velcade) in the fall of 2013. The hope is that this will increase the effectiveness of the pomalidomide (Pomalyst) and dexamethasone. By the way, pomalidomide is now being funded by the BC government's cancer agency. Good news! In my case, I will continue to receive it through the compassionate access program of its manufacturer, Celgene.
Recently I was asked to participate in a series of online videos being produced by the British Columbia Conference of the United Church of Canada. They are short (75 second) conversation starters about leadership in the church, part of a larger initiative in the Conference called "Leadershift." To date five videos have been produced, including this one in which I speak about the place of following in the life of a leader - Following with Humility.